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Semiflexible polymer scaffolds: an overview of
conjugation strategies
Lotte Gerrits,a Roel Hammink *b,c and Paul H. J. Kouwer *a
Semiflexible polymers play an important role in nature and possess remarkable properties that render them
efficient scaffolds. While flexible polymers coil up, semiflexible polymers are rigid enough to retain a straight
conformation and thus facilitate access to substituents on the polymer chain. This review describes how
semiflexible polymers function as scaffolds and which chemical strategies are used to conjugate substitu-
ents to this unique class of polymers. In general, biopolymeric scaffolds are functionalized through post-
functionalization strategies, which generates versatility but offers low spatial control. Synthetic polymeric
scaffolds can be designed and functionalized from scratch, which provides a larger freedom in design and
conjugation strategies. Altogether, this review summarizes the most important methods that are available to
the chemist, which have been developed to generate truly functional semiflexible scaffolds.
Introduction
In the last few decades, semiflexible polymers have spiked the
interest of many researchers. The main rationale behind the
growing interest in this class of polymers is that semiflexible
polymers and their striking properties play an important role in
living systems. In fact, many (structural) biopolymers, such as
collagen, DNA, and the cytoskeletal components are considered
semiflexible (Box 1).1–3 Due to their reduced flexibility, these
polymers exhibit unique properties such as the ability to recover
shape after withstanding external stress. These properties allow
the cytoskeleton, a dynamic three-dimensional network that
fills the cytoplasm, to give cells their overall shape and endure
external stress even at relatively low polymer concentrations.3,4
The properties of semiflexible polymers are not only useful in
nature. The unique conformation of these polymers enables
them to serve as a scaffold. Because semiflexible polymers do
not collapse into a random coil, they can be used as a relatively
rigid scaffold that can be decorated with all sorts of functional
substituents, which will be much better accessible than on flex-
ible polymers (Fig. 1A). In addition, semiflexible polymers are
typically long, one-dimensional structures, which allows for the
introduction of multiple of the same or different substituents
where one can benefit optimally from, for instance, multivalent
interactions, another design principle frequently used in nature.
Box 1 Unique properties of semiflexible polymers
To understand why semiflexible polymers behave differ-
ently than flexible polymers, it is important to define
what semiflexibility is. In general, polymers are defined
by two lengths: the total contour length (L) of the
polymer, and the persistence length (lp). The contour
length is the length of the fully stretched polymer
chain. The persistence length quantifies the polymer
stiffness (or flexibility) and is defined as the length
where the correlation of angles of the tangent vectors is
lost.5,6
A polymer is semiflexible when its total contour
length and its persistence length are of the same order
of magnitude.3 Polymers (or objects) with L ≪ lp act
like rigid rods, while polymer with L ≫ lp are fully
flexible. For semiflexible polymers, thermal fluctu-
ations contribute to their conformation; their behavior
is well-described by the Wormlike chain model.7
Some typical persistence lengths of natural and syn-
thetic polymers are given in Table 1, although care
should be taken that direct comparison is difficult
because of different measurement techniques and
conditions.
The difference in conformations between flexible and
semi-flexible polymers is important in the context
of scaffolds. In flexible polymers, thermal fluctuations
dominate and the chains coil up to maximize its
entropy. Functional substituents will be poorly
accessible. Semiflexible polymers are stiff enough that
a much more straight conformation is favored and
the substituents on the polymer will be readily
accessible.
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In this work, we review how researchers have used semiflex-
ible polymers as functional scaffolds and which strategies they
followed to introduce (functional) substituents, ranging from
small molecules to biomolecules as large as antibodies
(Fig. 1B). In the first part of the review, we focus on biopolymers
that form a primary source of semiflexible scaffolds and a
design inspiration for synthetic equivalents. Functionalization
of biopolymers primarily follows post-modification approaches,
unless the biopolymers can be custom-designed, such as DNA.
In the second part of the review, we discuss progress in syn-
thetic semiflexible scaffolds. For synthetic polymers, the
freedom to design is larger, which allows for different conju-
gation strategies.
Biopolymers
Semiflexible biopolymers are suitable scaffolds due to their
abundance in nature and unique properties. We divided biopo-
lymers in three main classes: polypeptides, polynucleotides
and polysaccharides, based on the monomer units and the
resulting polymer structure (Fig. 2). Generally, it is difficult to
modify the monomers of a biopolymer individually. As a
result, the introduction of substituents on a biopolymer
scaffold is commonly achieved via post-modification reaction
on the polymer chain, using accessible functional groups,
such as amines and thiols on polypeptides, phosphates on
polynucleotides and carboxylic acids and hydroxyls on polysac-
charides. The main drawback of this approach is that the selec-
tive introduction of substituents is not possible which results
in a loss of spatial control and thus gives rise to a less well-
defined scaffold.8 Here, we will describe and assess the
functionalization techniques that are used to introduce substi-
tuents on polypeptide, polynucleotide and polysaccharide
scaffolds.
From left to right: Roel Hammink, Lotte Gerrits and Paul
Kouwer
Roel Hammink is a postdoctoral researcher in the Tumor
Immunology group of Prof. Carl. G. Figdor. He received a Ph.D.
in polymer chemistry from the Radboud University Nijmegen in
2016. His current research focusses on the development of arti-
ficial antigen presenting cells, using polymers as a scaffold for
the delivery of immunolatory signals. Lotte Gerrits obtained
her MSc degree in Chemistry from the Radboud University in
Nijmegen in 2018. She is currently pursuing her PhD under
supervision of Dr Paul H. J. Kouwer and Dr Roel Hammink in
the Molecular Materials group at the same university. Her
research interest is focused on developing functionalized poly-
mers for immunotherapies. Paul Kouwer received his PhD
degree from the Delft University of Technology. He currently
holds an Associate Professor position in Molecular Materials at
Radboud University in Nijmegen, the Netherlands, where he
develops highly biomimetic polymer materials and hydrogels
for diverse biomedical applications. The three authors collab-
orate in an interdisciplinary project to develop new (semiflex-
ible) scaffold materials that are functionalized for immunologi-
cal application and that, ultimately, can be used for in vivo
immunotherapies.
Fig. 1 A. Schematic representation of the difference between flexible
(left) and semiflexible (right) polymer scaffolds. The more stretched
chain conformation of the latter provides a much better access to sub-
stituents grafted to the polymer. B. Schematic overview of the different
strategies for the introduction of substituents on semiflexible polymer
scaffolds as discussed in this review.
Table 1 Persistence lengths of some common polymersa
Polymer Persistence length
F-Actin 17 µm
Single-walled carbon nanotubes 10 µm
Double stranded DNA 50 nm
Collagen 20 nm
Alginate 15 nm
Hyaluronic acid 4 nm
Poly(3-hexylthiophene) 2 nm
Polystyrene 0.3 nm
aNote that persistence lengths given here are measured with different
techniques and in different conditions.
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Peptide-based biopolymers gained interest as a class of bio-
materials due to their unique biological, chemical and physi-
cal properties.9 They are easily degradable in the body, which
makes them desirable candidates for drug delivery and tissue
engineering applications.10 Furthermore, the ability of poly-
peptides to self-assemble into highly ordered structures pro-
vides new opportunities to develop functional biomaterials.9
Polypeptides consist of amino acid residues that are linked by
peptide bonds. Natural occurring polypeptides such as col-
lagen and fibrin consist of multiple polypeptide chains that
are aggregated to form stable protein complexes.11,12
Residual functional groups of the amino acid buildings
blocks provide active sites for the introduction of substitu-
ents on the polypeptide chains. In the next paragraphs we
will discuss the landmark semiflexible polypeptides collagen
and fibrin.
Collagen
Collagen is a cross-linked fibrous protein that consists of a
right handed bundle of three polypeptide chains which are
aligned in a parallel fashion and coiled into a left-handed poly-
proline II-type helix.11 Each polypeptide chain contains
around one thousand amino acid residues of which every third
residue is glycine (Gly).11 The repetitive presence of Gly
ensures tight packing of the three polypeptide chains into the
triple helix.13 Collagen is widely distributed in connective
tissues and can be formed into highly organized scaffolds
which are biocompatible, -degradable and non-toxic upon
exogenous application.13 Its fibers form the mechanical and
structural scaffold of bone, skin, blood vessel walls and other
connective tissues and is the most commonly used type of col-
lagen in medicine.13,14 As a consequence, the material is exten-
sively used as a scaffold for tissue engineering and wound
healing applications.13,15 Various active molecules such as
growth factors and antibiotics have been conjugated to col-
lagen scaffolds.16,17
Boyce and coworkers biotinylated collagen to conjugate
growth factors such as epidermal growth factor (EGF) and
heparin binding growth factor 2 (HBGF2) to modulate wound
healing.16,18 Both growth factors were attached to
collagen using a bridged avidin and biotin procedure. Biotin
was covalently bound to bovine skin collagen, EGF and
HBGF2 by reaction of biotinyl-N-hydroxysuccinimide (NHS)
with the amine-groups of lysine residues on the protein
(Fig. 3A). Biotinylated EGF and HBGF2 were subsequently
attached to collagen through the pendant avidin (Fig. 3B).
The authors showed both growth factors retained mitogenic
activity for cultured human epidermal keratinocytes
after biotinylation, thereby showing that their biotinylated
collagen scaffold is suitable for wound healing
applications.16
With a similar goal, Myung and coworkers covalently conju-
gated EGF to a collagen scaffold. They used strain-promoted
azide–alkyne cycloaddition (SPAAC) click chemistry to develop
a material for epithelial wound healing applications.19 EGF
was modified with an azide handle via reaction with azide-
OEG5-sulfo-NHS (OEG = oligo(ethylene glycol)) ester and sub-
sequently reacted with dibenzocyclooctyne (DBCO)-modified
collagen to obtain the EGF functionalized collagen scaffold
(Fig. 4A and C). The DBCO handles were introduced on col-
lagen via reaction of the lysine residues through (sulfo)-NHS
chemistry (Fig. 4B). The SPAAC anchoring method proved non-
toxic and biocompatible, highlighting its broader applicability
towards biomaterials. The resulting EGF-functionalized col-
lagen scaffold showed a significant increase in adhesion and
proliferation of epithelial cells compared to the soluble EGF
control, which underlines the advantage of presenting substi-
tuents on a scaffold. The group of Myung also applied the
SPAAC reaction to crosslink collagen fibers to develop a hydro-
gel with optimal mechanical properties to promote corneal
keratocyte growth for corneal stromal tissue engineering
applications.20
Fig. 2 Schematic structures of biopolymers: polypeptides, polynucleo-
tides and polysaccharides.
Fig. 3 A. The bridged avidin and biotin procedure for conjugation of
EGF and HBGF2 to collagen. NHS-functionalized biotin was conjugated
to collagen, EGF and HBGF2 via amide bond formation. Reprinted from
ref. 16 with permission from Elsevier, copyright (1989). B. Avidin (A) was
used a bridge between two biotinylated (B) compounds, the scaffold
and biotinylated growth factors EGF or HBGF2. Reprinted from ref. 18
with permission from John Wiley and Sons, Copyright (1969).
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Since collagen constitutes the majority of the extracellular
matrix, scaffolds of collagen are highly attractive as a three-
dimensional (3D) cell culture matrix for promotion of cell
growth and differentiation, either for tissue engineering
ex vivo or as an implant. Li and coworkers developed a collagen
scaffold with Cetuximab to steer differentiation of neural pro-
genitor cells (NPCs) for repair of spinal cord injuries.21
Cetuximab was covalently linked to the collagen scaffold via
the use of a hetero-bi-functional crosslinker (Fig. 5). To intro-
duce a thiol group, collagen was reacted with Traut’s reagent,
which conveniently reacts efficiently with primary amines at
pH 7 to 9. A free amine on Cetuximab was conjugated to the
commercially available sulfo-succinimidyl-4-(N-maleimido-
methyl)cyclohexane-1-carboxylate (Sulfo-SMCC) crosslinker. A
subsequent reaction of the thiolated collagen scaffold with the
maleimide group of Sulfo-SMCC gave the Cetuximab-decorated
collagen. An enzyme-linked immunosorbent assay (ELISA)
showed that more Cetuximab was retained on the collagen
scaffold through covalent linking compared with physical
absorption, demonstrating the advantage of chemical modifi-
cation of a scaffold. NPCs cultured on Cetuximab functiona-
lized collagen scaffolds demonstrated neuronal differentiation
in vitro while rats subjected to a spinal cord hemisection fol-
lowed by treatment with Cetuximab functionalized collagen
showed successful formation of neurons in vivo.
Puoci et al. conjugated Ciprofloxacin (CFX), an antibiotic,
to collagen.17 Collagen was activated towards radical insertion
of CFX via attack of the labile residues with hydroxyl radicals,
which are formed through the oxidation of ascorbic acid by
H2O2, followed by insertion of CFX. The obtained material
showed antimicrobial activity and stimulation of fibroblast
growth, supporting its applicability as wound dressing.
Fibrin
Similar to collagen, fibrin is one of the main components of
the extracellular matrix (ECM) and plays an important role as
scaffold for tissue engineering applications. Fibrin biopoly-
mers consist of protofibrils that self-assemble and bundle into
semiflexible fibers (Fig. 6). The precursor of fibrin is fibrino-
gen, a protein that consists of three polypeptide chains,
named Aα, Bβ and γ.22 Polymerization into fibrin is initiated
by thrombin, which cleaves the protective fibrinopeptides FpA
and FpB, initiating a two-step assembly process. In the first
step, double-stranded protofibrils form after cleavage of FpA.23
Subsequently, cleavage of FpB promotes clustering of the pro-
tofibrils into fibers constituting up to hundreds of protofi-
brils.24 Enzyme factor XIII (FXIII) catalyzes the formation of
crosslinks between Aα and γ, which causes a closer packing of
the protofibrils in the fibrin fibers.25 A widely applied strategy
to introduce functionalities on fibrin is via feeding of a modi-
fied substrate to FXIII, which then incorporates the modifi-
cation into the fibrin fibers. Several proteins, genes and
peptide–DNA conjugates have been introduced on a fibrin
scaffold via this method.26–29
Fig. 4 Covalent conjugation of EGF to collagen via SPAAC ‘click’
chemistry. A. Introduction of azide handle to EGF via sulfo-NHS
chemistry. B. Functionalization of collagen with DBCO via reaction via
the lysine residues. C. Schematic overview of EGF coupling of collagen
scaffold via SPAAC click chemistry. Reprinted from ref. 19 with per-
mission from American Chemical Society, copyright (2017).
Fig. 5 Conjugation of Cetuximab to the collagen scaffold. Reprinted
from ref. 21 with permission from Elsevier, copyright (2013).
Fig. 6 Schematic overview of Fibrin formation and incorporation of
substituents (R) via modification of enzyme factor XIII (FXIII).
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Banfi and coworkers used fibrin as a scaffold for the delivery
of recombinant VEGF to induce angiogenesis.30 The N-terminus
of murine VEGF164 was fused to a peptide substrate for FXIII,
which binds VEGF164 to fibrin during fibrinogen crosslinking (R
group in Fig. 6). Bound VEGF164 is released from the scaffold via
degradation of fibrin by proteases. The biodegradability of
natural polymers marks a big advantage for biopolymeric
scaffolds towards medical applications, as most synthetic poly-
mers lack this feature. Implantation of the VEGF164 functiona-
lized fibrin hydrogel in murine models of ischemic wound
healing showed that sustained release of VEGF164 induced
normal angiogenesis, which improved tissue perfusion and accel-
erated wound healing. This strategy, where the molecule of inter-
est is fused to a peptide substrate for FXIII, was applied to func-
tionalize fibrin scaffolds with various proteins such as β-NGF,
αvβ3 integrin and DNA sequences.27,29,31
Nam et al. conjugated synthetic laminin-111 to fibrinogen
monomers to prepare a fibrin hydrogel that promotes tissue
regeneration in submandibular glands.32 To covalently bind
the peptide, primary amines on fibrinogen were functionalized
with a sulfo-LC-SPDP linker via NHS chemistry (Fig. 7A). The
pyridylthiol reactive group enabled binding of the peptides via
disulfide bond formation with residual thiols. The functiona-
lized fibrinogen monomers were subsequently polymerized to
form the laminin-111-functionalized fibrin hydrogel, which
showed regeneration of gland tissue in vivo. This functionali-
zation strategy was also applied to introduce other peptides
and growth factors on fibrin scaffolds.33–35
Another method for functionalization of fibrin was applied
by Zhao et al.36,37 Here, fibrinogen was functionalized with
aptamers, which can bind the growth factors VEGF and plate-
let-derived growth factor (PDGF) to promote angiogenesis after
fibrin polymerization. The aptamers were covalently bound to
fibrinogen via a Michael addition. The primary amines on
native fibrinogen were acylated with NHS-acrylate. Thiolated
anti-VEGF or anti-PDGF aptamers were then reduced and
reacted with the acrylates on fibrinogen to form to Michael
adduct (Fig. 7B). The aptamer-functionalized fibrinogen
monomers were polymerized using thrombin to form fibrin
hydrogels comprising VEGF and PDGF binding domains
(Fig. 7C). In vitro studies of VEGF and PDGF loaded fibrin gels
showed increased retention and significantly slower release of
the growth factors compared to the release from native fibrin
gels. The effect of the dual growth factor release on angio-
genesis was examined both in vitro and in vivo and demon-
strated promoted formation of stable blood vessels. A follow-
up study with a VEGF-aptamer functionalized fibrin hydrogel
loaded with VEGF demonstrated enhanced angiogenesis and
osteogenesis in vivo compared to soluble VEGF loaded fibrin
hydrogel,38 which demonstrates the advantage of scaffold
functionalization. Other work showed the applicability of this
approach to promote the survival of transplanted mesenchy-
mal stem cell (MSC) spheroids in vitro, ultimately for the devel-
opment of various tissue-engineering materials.39
Both collagen and fibrin are readily functionalized by using
the functional groups on their backbones. Consequently, regio-
selectivity is difficult to realize and modifications are randomly
introduced in the structure. In addition, fibrin can be modi-
fied through FXIII which is spatially controlled, albeit less
dense.
Polynucleotides
Polynucleotides consist of a sequence of nucleotide monomers
that are linked through a covalent bond between the phos-
phate group and the pentose sugar of each nucleotide, result-
ing in a sugar-phosphate backbone (Fig. 1). In nature, DNA
exists in a double stranded form (dsDNA) comprising two poly-
nucleotide chains that bind via the formation of hydrogen
bonds between the complementary nucleobases. On the other
hand, RNA primarily occurs as a single polynucleotide chain.
DNA, as well as RNA are considered to be semiflexible.6,40 This
fact, combined with their abundance in nature, makes them
suitable scaffolds for bioengineering applications. As DNA and
RNA can be assembled into highly ordered nanostructures,
these biopolymers serve as excellent scaffolds to conjugate a
variety of molecules which are subsequently presented on
such nanostructures.
DNA nanostructures
Over the past few years, a wide variety of well-defined, compact
3D DNA nanostructures has been synthesized through the
DNA origami technique,41 or via the single-stranded DNA tiles
technique, which uses single-stranded DNA (ssDNA) as bricks
that assemble into well-defined DNA nanostructures.42 Due to
their high spatial control, DNA nanostructures provide excel-
lent scaffolds for introduction of substituents. Peptides and
proteins have been conjugated to DNA nanostructures with
well-controlled intermolecular distances and relative ratios.43
In the next paragraphs, we will focus on protein conjugation to
DNA, which is frequently pursued for development of bio-
sensors, drug delivery systems and multi-enzyme networks.
Nucleic acids and their polymers have been chemically
modified at several positions: at the nucleobase, the sugar, the
Fig. 7 Introduction on substituents on fibrin via fibrinogen
functionalization. A. Introduction of peptides on fibrinogen (Fg) via modifi-
cation with sulfo-NHS-LC-SPDP linker to enable conjugation with thiol
residues via disulfide formation. B. Introduction of aptamers on Fg mono-
mers via acrylate-thiol Michael addition. C. Formation of fibrin hydrogels
and subsequent binding of growth factors. Reprinted from ref. 36 with
permission from American Chemical Society, copyright (2019).
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phosphate backbone and the chain termini (Fig. 8A).
Chemical modification at the base and sugar positions is
laborious and requires the nucleobase hydrogen bond patterns
to remain intact.44 Functionalization at the chain ends or at
the phosphate backbone is synthetically easier and, therefore,
more applied. A variety of methods for protein–DNA conju-
gation have been developed, which can be divided in covalent/
non-covalent, and site-specific/non-site-specific methods. To
enable conjugation with biomolecules, the 5′-terminus of a
polynucleotide chain has been modified with functional
groups such as amines, azides and thiols.43,44 Most of these
functionalized DNA strands are readily synthesized by auto-
mated solid-phase synthesis or are commercially available.43
One of the most studied methods for non-covalent site
specific binding of proteins to DNA is binding through biotin–
streptavidin (Sav) interactions (Fig. 8B),45 which conjugates in
mild conditions and with high affinity.46 The 5′-end of the
DNA strand is easily biotinylated. Proteins are functionalized
with Sav via protein engineering, which is laborious and
remains challenging.47 The use of monomeric Sav circumvents
stoichiometry difficulties and ensures efficient conjugation.48
Other common non-covalent protein–DNA binding strategies
include antigen–antibody binding49 and nitriloacetic acid
(NTA)-Ni2-Histag binding.50 These methods require the 5′-end
binding of an antigen, through solid phase synthesis,49 or a
NTA moiety through the reaction of thiolated DNA with male-
imide-C3-NTA.51
Covalent site-specific conjugation of proteins to DNA nano-
structures (Fig. 8C) requires proteins to express a chemical
handle that can selectively react with a functional group on the
DNA scaffold. Such techniques require genetic manipulation
of the protein of interest, which is challenging and needs
optimization for each newly studied protein.43 Extensive
reviews on the various approaches towards site specific conju-
gation of proteins have been published recently.43,52 A
common and chemically relevant approach towards site-
specific ligation is azido protein–DNA conjugation. In this
strategy, the protein of interest is mutated with an azido group
via incorporation of unnatural amino acids such as azido-
homoalanine.53 The 5′ end of a DNA strand can be functiona-
lized with a complementary group that enables a selective reac-
tion with the azide. The frequently used terminal alkyne needs
a Cu(I) catalyst for the cupper-catalysed azide–alkyne cyclo-
addition (CuAAC), which presents biological drawbacks,
including cell toxicity and loss of enzyme activity.43 The SPAAC
reaction forms a suitable alternative and needs DNA modifi-
cation with groups such as bicyclononyne (BCN),54 dibenzoan-
nulated cyclooctyne55 or dibenzocyclooctyne (DBCO).56
Fig. 8 A. Structure of DNA and functionalization positions. B. Methods for non-covalent site-specific binding of proteins to a DNA scaffold. 6×His =
hexahistidine tag. C. Method for covalent site-specific binding of proteins to a DNA scaffold. Reprinted from ref. 60 with permission from Nature
Springer: Nature Catalysis, copyright (2020). D. Methods for covalent non-site-specific binding of proteins to a DNA scaffold. D.2 Reproduced from
ref. 63 with permission from the Royal Society of Chemistry, copyright (2019). D.3 Reprinted from ref. 64 with permission from Nature Springer:
Nature Nanotechnology, copyright (2014).
Polymer Chemistry Review


































































































Using these strategies various proteins of interest have been
conjugated on a DNA scaffold.57–59 Rosier et al. applied site-
specific protein–DNA conjugation to develop a DNA-origami
based synthetic apoptosome.60 Caspase-9 was conjugated to
ssDNA via a SPAAC reaction between p-azidophenylalanine
incorporated in the enzyme and BCN-functionalized ssDNA
(Fig. 8C). Subsequent hybridization of the enzyme-ssDNA con-
struct with complementary strands on a DNA origami platform
resulted in the formation of a well-defined enzyme-DNA nano-
structure, offering proximity-induced Cas9 enzyme activity.
Covalent non-site-specific protein–DNA conjugation strat-
egies circumvent problems related with dissociation of non-
covalent interactions. Generally, a protein is conjugated to
DNA via the use of a heterobifunctional linker. The most
common linkers contain a maleimide functionality and an
NHS-ester to bind thiolated DNA strands to a protein via lysine
residues.61 The heterobifunctional linker SMCC was used by
Chaput and co-workers to develop a synthetic antibody.62
Chaput created a bivalent protein affinity reagent by conjugat-
ing peptide ligands on a DNA scaffold. To enable binding of
peptide ligands, ssDNA was modified with a terminal amine,
which was reacted with the NHS ester of the SMCC linker
(Fig. 8D). Subsequent reaction of the maleimide on the linker
with the C-terminal cysteine on the peptide yielded in peptide-
functionalized DNA strands that self-assembled into a bivalent
DNA–peptide scaffolds with tailorable peptides positions,
which ultimately could bind a target protein with a 1000-fold
higher affinity than the individual peptides. This result is a
clear example of how a well-defined scaffold promotes a multi-
valent presentation of biomolecules.
Another covalent conjugation strategy was applied by the
group of Carneiro, who coupled polyaspartic acid (pAsp) to
ssDNA to develop pAsp functionalized nanostructures for
enamel regeneration.63 The N-terminus of pAsp was functiona-
lized with a thiol group through acetylation of the N-terminus
followed by nucleophilic substitution with thioacetic acid and
subsequent deprotection. The resulting terminal thiol was
reacted with a maleimide functionalized DNA strand contain-
ing a sticky end. The pAsp functionalized DNA strand was then
combined with two other DNA strands to form a three-
stranded double helix in which the pAsp particle always faces
the same side of the DNA duplex at a pre-defined distance
(Fig. 8D). The results highlight that the DNA assembly tech-
nique, which resembles a block-copolymer approach by
employing functionalized oligonucleotides as monomers that
are incorporated on DNA strands, enables introduction of sub-
stituents on a DNA scaffold with high spatial control.
DNA assembly proves a powerful strategy to introduce
different moieties (enzymes and synthetic polymers) on a
scaffold with high spatial control.64–66 Fu et al. used DNA
assembly to develop a multi-enzyme complex in which a syn-
thetic swinging arm facilitates hydride transfer between two
hydrogenases conjugated on a DNA scaffold.64 Lysine residues
on the hydrogenases were reacted with the NHS ester of a com-
mercially available succinimidyl 3-(2-pyridyldithio)propionate
(SPDP) heterobifunctional linker (Fig. 8D). The resulting
enzyme constructs were coupled to thiolated ssDNA via clea-
vage of the pyridylthiol reactive group of the SPDP linker. The
synthetic swinging arm, consisting of NAD+-functionalized
poly(thymine)20, was conjugated to ssDNA through coupling
with disuccinimidyl suberate; both NHS-esters reacting with
the primary amines on amine functionalized ssDNA and
NAD+-functionalized poly(thymine)20. Subsequent DNA hybrid-
ization on the DNA scaffold gave rise to a multi-enzyme
complex with excellent enzyme activity. The unparalleled
spatial control that DNA scaffolds offer allows for manipu-
lation and optimization of (bio)functionality, in this example
enzyme activity.
RNA nanostructures
Although RNA (Fig. 9) is chemically similar to DNA, there are
some key differences in their structures. In nature, DNA pri-
marily exists as a double stranded helix, while most RNA is
single stranded. The RNA helix has a smaller pitch and is
shorter than that of DNA.67,68 Despite the differences, strat-
egies for the development of DNA nanostructures can be
extended to design RNA nanostructures, as long as minor
modulations, such as changing the duplex length are con-
sidered.69 In this way, the DNA origami technique was extrapo-
lated to RNA by replacing the DNA staples with RNA staples.
RNA tiles, analogous to DNA tiles, were designed, which were
self-assembled into uniform nanostructures.70,71 Because RNA
has different tertiary folding and assembly principles than
DNA, different nanostructures can also be designed, which
leads to new scaffolds for substituent presentation. As this
review focusses on the application of RNA nanostructures
as scaffolds, only a short overview is given on the various
types of RNA nanostructures. The design and structure of RNA
nanostructures themselves has been reviewed elaborately
elsewhere.72
Tertiary structures of RNA consist of lower order structural
motifs, which can function as building blocks for nanoassem-
blies. RNA structural motifs can bend, link or branch RNA
molecules, which further expands the toolbox for organization
at the nanometer scale.69 Due to the large variety of known
structural motifs, an infinite number of RNA nanostructures
Fig. 9 RNA structure and functionalization positions.
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can be designed.73 Similar to DNA, RNA nanostructures can
function as a scaffold for the introduction of functional mole-
cules. Aptamers, chemical ligands, fluorescent dyes and other
functional molecules have been fused to RNA strands prior to
their assembly into nanostructures.74 However, because RNA is
chemically labile, introduction of functional molecules on
RNA scaffolds via chemical modification is problematic.75
Therefore, fusion of functional molecules to RNA strands is
commonly achieved through modification of the functional
molecule with a phosphoramidite group followed by coupling
to the 3′ or 5′ end of RNA (Fig. 10). Through this method, fluo-
rescent dyes and folate have been conjugated to RNA nano-
particles; the latter with the goal to target tumor cells, which
are known to overexpress folate receptors.76 Protein binding
RNA scaffolds can be prepared through the incorporation of
aptamers in RNA structural motifs. A nanostructure based on
the packaging RNA three-way junction motif was functiona-
lized with four binding aptamers to develop a multifunctional
RNA–protein nanostructure (Fig. 10).77 RNA aptamers are rela-
tively easily attached to the nucleotide chain of RNA motifs,
which allows for subsequent binding of proteins of interest
and further assembly into nanostructures.
Another method for the introduction of proteins on RNA
nanostructures makes use of RNA recognition motifs, i.e. a
region on the RNA strand that is recognized and bound by the
protein.78 Using such RNA recognition motifs, Shibata et al.
developed a RNA nanostructured device that can control cell
fate via RNA–protein interaction-mediated protein assembly.79
For instance, K-turn RNA and the RNA-binding protein L7Ae
function as RNA–protein interaction motif. L7Ae was fused
with caspase-8 (Casp8) to develop a nanodevice that induces
cell death. RNA scaffolds containing various amounts of
K-turn motifs were developed. Populations with cell-death
were observed for cells that were co-transfected with L7Ae-
Casp8 and RNA scaffolds containing a higher number of
K-turn motifs, suggesting that cell-death signals can be tuned
by changing the number of assembled Casp8 proteins on the
scaffold. These results show that RNA scaffolds can localize
target proteins and induce strong biological effects.
Although a wide variety of DNA and RNA scaffolds with
potential therapeutic application have been synthesized, their
use remains restricted. Due to their phosphodiester backbone,
synthetic oligonucleotides are susceptible to degradation by
nucleases.80 This process makes the in vivo application of DNA
and RNA scaffolds a challenge. Peptide nucleic acid (PNA) can
circumvent degradation by nucleases, as its backbone is com-
posed of peptides.81
Peptide nucleic acids (PNAs)
A PNA (Fig. 11) is a modified DNA equivalent that contains a
neutral peptide backbone instead of a negatively charged
sugar-phosphate backbone. Unlike DNA and RNA, PNA is
chemically stable and resistant to enzymatic degradation in
living cells. Functional groups are most often introduced on
the backbone of PNA by modification of the α (C-2) or γ (C-5)
position of the PNA monomer.82 Modification of the backbone
of PNA introduces chirality and, therefore requires enantio-
selective synthesis. Chirality can be introduced by starting the
synthesis with synthons such as D- or L-amino acids.
Monomers that are functionalized at the α position may suffer
from epimerization when used in solid phase synthesis, which
makes it difficult to obtain optically pure PNAs.
Optical purity for α modified PNA is improved by a submo-
nomeric approach, in which the nucleobase is introduced after
linking the peptide to the PNA backbone.83 Modification of
the α position with positively charged side chains improves cel-
lular uptake and duplex stability but introduction of neutral or
negative charged side chains on that position destabilize
duplex formation.84,85 Synthetic bottlenecks and restricted
options of functional groups limit the use of α modified PNA
as a scaffold. Optical purity is easier obtained for PNAs com-
prising γ modified monomers. For example, optically pure
PNA monomers derived from L-amino acids were prepared
using a Mitsunobu reaction with t-butyloxycarbonyl (Boc)-pro-
tected α amine (Fig. 12A, route i) or via reductive amination
with protection of the α amine with 9-phenylfluorenyl group
(route ii).86
Appella and coworkers used L-lysine γ-PNA as building
blocks to synthesize PNA oligomers containing various func-
tional groups.85 The primary amine of the lysine chain was
used to conjugate a variety of groups such as acetamide, phe-
Fig. 10 RNA nanostructure based on the three-way junction motifs
that binds proteins via interaction with protein specific aptamers on the
RNA motif. Reprinted from ref. 77 with permission from American
Chemical Society, copyright (2018). Fig. 11 Structure of PNA and functionalization positions.
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nylpropanoic acid, small peptide chains and fluorescent
groups. Introduction of these functional groups was carried
out using fluorenylmethyloxycarbonyl (Fmoc) protected amine
residues, which were deprotected during PNA oligomer syn-
thesis on solid support. After deprotection, carboxylic acids
were coupled using hexafluorophosphate benzotriazole tetra-
methyl uronium as a coupling reagent (Fig. 12B). The authors
found that introduction of these functional groups did not
interfere with the ability of PNA to bind complementary
nucleic acid sequences, showing that PNA can function as an
excellent scaffold for the development of for instance nucleic
acid detection systems and antisense molecules.87,88
A more straightforward method to introduce functionalities
is through modification of the PNA nucleobase, which circum-
vents the introduction of chiral centers. To this end
C-5 modified pyrimidines were developed using 5-hydroxy-
methyl uracil, and 5-iodocytosine as building blocks.89
5-Hydroxymethyluracil is easily obtained from uracil
through reaction with formaldehyde.90 Dambenieks and co-
workers conjugated a variety of functionalities such as carbo-
hydrates, cationic groups and oligo(ethylene glycol) tails to
hydroxymethylated uracil PNA monomers (Fig. 13A).89 The
5-iodonucleobase allows for introduction of alkynyl derivatives
using the Sonogashira coupling. Using this method, fluo-
rescent groups were conjugated to PNA monomers and sub-
sequently incorporated in PNA oligomers to detect increased
binding affinity with DNA.91 Substitution at the C-6 position of
pyrimidines is slightly more sensitive to steric effects than the
C-5 position as it is closer to the PNA backbone, making intro-
duction of functional groups at the C-6 position less favorable.
Analogously, PNA monomers bearing 5-azidomethyluracil
were developed as a versatile building block for the introduc-
tion of functional groups.92 This building block is easily
obtained via acid catalyzed nucleophilic substitution of the
hydroxyl of hydroxymethylated uracil with chloride, followed
by conversion into an azide using sodium azide. Introduction
of a carboxymethylene linker at the N-1 position of uracil
enables the insertion on the PNA backbone. The azido group
can be converted into an amine to enable conjugation of car-
boxylic acid containing substituents, or it can be used to
couple alkyne containing substituents via CuAAC or SPAAC
click chemistry. Both conjugation strategies can also be
applied on PNA oligomers which enables post-modification of
the PNA scaffold. Manicardi et al. applied this strategy to intro-
duce pyrenes on a PNA scaffold to develop a PNA-based probe
that detects target oligonucleotides via a conversion in fluo-
rescence emission upon hybridization.93
Another approach was developed by Hudson and co-
workers, who synthesized an azide containing PNA monomer
without nucleobases (Fig. 13C).94 Hudson and coworkers
argue that conjugation of a modified base to the monomer
backbone is laborious and leads to loss of material during
purification, which can be circumvented by the use of a reac-
tive monomer that can be transformed into a variety of deriva-
tives. To this end, azidoacetic acid was directly conjugated to
the PNA backbone (Fig. 13B). To demonstrate its post-modifi-
cation abilities, the azido PNA monomer was incorporated into
an oligonucleotide using solid-phase peptide synthesis (SPPS),
and subsequently conjugated to a fluorophore while on the
solid support. This on-resin approach is beneficial for the
copper mediated click reaction between the azido modified oli-
gomer and the alkyne containing fluorophore, as it enabled
using an excess of reagents and simplified the purification.
The resulting fluorophore functionalized PNA scaffold func-
tioned as a probe for detecting abasic sites on oligonucleo-
tides. The on-resin method facilitates easy derivatization of
PNAs via separation of the resin and subsequent modification
reactions. Furthermore, SPPS of PNA scaffolds gives the oppor-
tunity to introduce functional groups with high spatial control,
comparable to the DNA assembly approaches.
Polysaccharides
Polysaccharides are linear or branched long chains of carbo-
hydrate molecules that are linked via glycosidic bonds (Fig. 1).
Linear polymers such as alginate, cellulose, chitin, chitosan
and hyaluronic acid are semiflexible and have a high abun-
dance in nature, which makes them interesting for scaffold
appliations.95–98 The ample amines, primary hydroxyls and
carboxylic acids on polysaccharide chains provide active sites
to introduce substituents. The open-chain aldehyde form of
the terminal monosaccharide can also be subjected to modifi-
cations such as reductive amination. An overview of the possi-
bilities for chemical modifications on polysaccharides was
reviewed earlier.99 Here, we focus on polysaccharides as
Fig. 12 A. Synthesis of optically pure γ-PNA monomers via reductive
amination (1) and Mitsunobu coupling (2). Reprinted from ref. 86 with
permission from Elsevier, copyright (2015). B. Introduction of various
functional groups (R) on PNA oligomers via functionalization of L-lysine
γ-PNA building blocks via SPPS. Reprinted from ref. 85 with permission
from John Wiley and Sons, copyright (2007).
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scaffolds and describe the modification and conjugation strat-
egies used to introduce substituents on these scaffolds.
Hyaluronic acid
Hyaluronic acid (HA) is an anionic glycosaminoglycan of
D-glucuronic acid (D-GlcA) and N-acetyl-D-glucosamine
(D-GlcNAc) disaccharide units which are linked via β-1,3 and
β-1,4 glycosidic bonds (Fig. 14). Hyaluronan synthases produce
long HA chains with an average contour lengths of >15 µm
(Mw > 7 MDa).
100 HA is a chief component in the ECM and
plays an essential role in tissue regeneration.101 Due to its
physical and biochemical properties, HA is gaining interest in
biomaterials science for applications such as bone regener-
ation, drug delivery, wound healing and tissue engineering.102
The combination of its straightforward chemical modifi-
cation, biocompatibility and degradability make HA a particu-
larly attractive scaffold for biochemical applications.103
Particularly, the primary hydroxyl of D-GlcNac and the car-
boxylic acid of D-GlcA are readily modified and can function as
handles for conjugation of HA with various substituents. The
anticancer drug Dihydroartemisinin (DHA) was conjugated to
a HA scaffold to improve its bioavailability.104 HA itself can
function as a tumor targeting ligand as it can bind to CD44, a
transmembrane glycoprotein and cell surface receptor for HA,
and RHAMM, a receptor for HA-mediated motility. DHA was
coupled to HA via ester bond formation between the hydroxyl
of DHA and the carboxylic acid of HA (Fig. 15A). Because of its
amphiphilic character, the HA–DHA conjugate forms nano-
particles in aqueous solution, resulting in a higher bio-
availability than DHA, which is poorly soluble in aqueous solu-
tions due to its lipophilic character. In vitro cytotoxicity tests
Fig. 13 A. Functionalization of PNA via nucleobase modification. 1. Introduction of carbohydrates and oligo(ethylene glycol) on a PNA monomer via
reaction with 5-hydroxylmethyluracil. Adapted from ref. 89. 2. Introduction of fluorescent groups on a PNA monomer via Sonogashira coupling with
5-iodocytosine. B. Modification of 5-azidomethyluracil towards introduction of pyrenes on a polynucleotide scaffold. Reproduced from ref. 93.
https://pubs.acs.org/doi/10.1021/acs.orglett.6b02363. Reprinted with permission from ACS, copyright (2016). Further permissions related to the
material excerpted should be directed to the ACS. C. 1. Direct modification of the PNA backbone with 2-azidoacetic acid. 2. Post-functionalization
of a PNA sequence with fluorescent groups (PNA-F and PNA-P) via CuAAC reaction. Reprinted from ref. 94 with permission from Taylor & Francis,
copyright (2013). 3. Detection of target oligonucleotides via hybridization and subsequent fluorescence. Reprinted from ref. 94 with permission
from Taylor & Francis, copyright (2013).
Fig. 14 Structure of hyaluronic acid (HA) and its functionalization
positions.
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indicated that the efficacy of DHA is enhanced when conju-
gated to HA, which demonstrates the targeting and solubility
effect of the HA scaffold.
Shen and co-workers also applied the targeting ability of
HA for the delivery of Cu(II)-chlorophyll (Cu(II)Chl) to cancer
cells105 and subsequent photodynamic/photothermal
therapy.106,107 Cu(II)Chl-HA nanoparticles were generated in
two steps: first PEG-diamine was covalently linked to the car-
boxylic acid of Cu(II)Chl after NHS activation; then the result-
ing PEG-Cu(II)Chl was conjugated to the NHS-activated HA to
form a carbamate linkage (Fig. 15B). In vitro, the construct
showed good selectivity for CD44-overexpressing cancer cells
and high cell-killing efficacy upon irradiation at 650 nm.
In vivo mouse experiments show decreasing tumor volumes on
treatment. These results demonstrate how HA can be used as a
scaffold for targeted delivery of drugs.
Hyaluronic acid is extensively studied as a scaffold for
tissue engineering applications as it has the ability to induce
intracellular signal transduction and can affect cell activities
such as proliferation and differentiation.108,109 HA hydrogels
are frequently used as a designer matrix for 3D cell culture or
for wound healing purposes. The gels, however show poor
mechanical properties and undergo rapid degradation
in vivo.102 Crosslinking and chemical modification can circum-
vent these disadvantages.
Chaudhuri and coworkers developed a HA hydrogel with
adjustable crosslinks to resemble the dynamic ECM microenvi-
ronment.111 To synthesize a hydrogel with tunable stress-relax-
ation, HA was crosslinked via hydrazone bond formation.
Hydrazone formation is efficient, biocompatible and can form
dynamically exchangeable crosslinks, which form the basis of
the controlled stress relaxation profiles in the HA hydrogels.112
The carboxylic acid of HA was NHS-activated and coupled to
propargyl amine, which was then transformed via the CuAAC
reaction to HA decorated with either hydrazine or aldehyde
groups (Fig. 16). Upon mixing both, hydrazone crosslinked
hydrogels readily formed and their tunable stress relaxation
was established with rheology. Next, dynamic HA-collagen
hydrogels were developed to form matrices for 3D cell culture.
Investigation of cell morphology showed that faster hydrogel
relaxation promotes cell spreading, collagen fiber realignment,
and focal adhesion (FA) formation. Functionalization of the
HA scaffold with such dynamic covalent crosslinks enables
development of synthetic 3D cell cultures in which function
and fate of cells can be directed, comparable to the ECM.
To enhance the stability of HA hydrogels, Lee et al. cross-
linked the hydroxyls of HA with poly(ethylene glycol) (PEG)
diglycidyl ether.113 Additionally, tannic acid (TA) that was
incorporated via hydrogen bond formation, gave the hydrogel
improved mechanical properties, and, as a hyaluronidase
inhibitor, also provided enzymatic stability. A similar chemical
approach was taken by Lin and coworkers, who crosslinked HA
with 1,4-butanediol diglycidyl ether (BDDE) followed by the
introduction of chlorhexidine (CHX) to develop an antibacter-
ial hydrogel for pacemaker pocket infection prevention.114 The
pre-crosslinking with BDDE ensured formation of a stable but
injectable hydrogel, while the weak physical bonding between
the imines of CHX and the carboxylic acids of HA facilitated
continuous release of CHX.
Bencherif and coworkers developed methacrylated HA to
incorporate covalent crosslinks in gels and nanogels after free-
radical photopolymerization.115–117 Methacrylate groups were
introduced on a HA scaffold via reaction of the carboxylic
acids or the primary hydroxyls with the epoxides of glycidyl
methacrylate (Fig. 17A) with good control over the degree of
methacrylation (DM).118 Subsequent photo crosslinking of HA
with varying DM yielded hydrogels with tailorable material
properties; the DM affects the crosslinking density, mechanical
properties and swelling ratios. Methacrylated HA (MeHA)
hydrogels are effective scaffolds for drug delivery as they
demonstrate excellent swelling ratios and are biodegradable.
Fig. 15 A. Conjugation of DHA on a HA scaffold to form HA–DHA
nanoparticles (NPs). Reprinted from ref. 104 with permission from
Elsevier, copyright (2019). B. Conjugation of Cu(II)CHl on a HA scaffold
to prepare Cu(II)Chl-HA NPs. Reproduced from ref. 110 with permission
from the Royal Society of Chemistry, copyright (2019).
Fig. 16 Crosslinking of HA with adjustable crosslinks. A. Propargylamine
was conjugated to NHS-activated HA. Aldehyde and hydrazone function-
alities were introduced via CuAAC chemistry. B. Crosslinking of HA via
dynamic hydrazone bond formation. Adapted and reprinted from ref. 111
with permission from Elsevier, copyright (2018).
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In a follow-up paper, the group incorporated methacrylated
nanogels that give additional control over drug release.115
To develop ideal microenvironments for tissue engineering
facilitating cellular growth in 3D, a scaffold resembling the
interconnected macroporous structure of tissue is desirable.
To this end, the Bencherif group developed an ECM-based
cryogel from MeHA.116 PEG diacrylate was used as a cross-
linker and was covalently linked to MeHA trough free radical
polymerization under freezing conditions (Fig. 17B). The
resulting cryogel exhibited a macroporosity of 75% and sup-
ported infiltration of cartilage cells. Culturing of rabbit chon-
drocytes on the cryogels gave rise to stimulated collagen type II
gene expression and collagen accumulation. Another HA-
based cryogel was developed through crosslinking with algi-
nate (see next section).117 Both polysaccharides were functio-
nalized with methacrylates, which enabled chemical cross-
linking through free radical polymerization. The resulting
cryogel displayed suitable mechanical properties and bioactiv-
ity, and regained their original shape and size after injection.
The straightforward introduction of methacrylate groups on
HA scaffolds together with the promising properties of the
resulting cryogels clearly demonstrate the efficacy of polysac-
charide-based cryogels for tissue engineering applications.
Alginate
Alginate is a linear copolymer derived from Phaeophyceae
seaweed and consists of residues of 1,4-linked β-D-mannuronic
acid (M-block) and α-L-guluronic acid (G block) residues
(Fig. 18).119 Alginate chains are composed of a random
sequence of alternating M-, G- and MG-blocks. Because of its
biocompatibility and tailorability, alginate is a suitable candi-
date for a variety of biomedical applications.120 Furthermore,
aqueous alginate solutions crosslink and gel almost instantly
in the presence of multivalent cations, which results in the for-
mation of hydrogels with highly tunable mechanical
properties.119,121 The gels are suitable as vehicles for delivery
of cells, genes and drugs.122–124 In analogy to HA, the car-
boxylic acid groups in alginate can be employed for cross-
linking or introduction of substituents and for covalent as well
as ionic crosslinking. Thus far, crosslinking has been largely
limited to the formation of ionic bridges between polymer
chains via the use of divalent cations such as Ca2+. Such gels
are weak and lose their mechanical integrity in vitro and
in vivo.125
To circumvent the bottlenecks of cationic crosslinking,
Desai et al. developed alginate hydrogels that are crosslinked
via click chemistry, using the biorthogonal inverse electron
demand Diels–Alder (IEDDA) reaction between tetrazine and
norbornene.126 To this end, alginate was functionalized with
norbornene and tetrazine by reacting the carboxylic acid with
norbornene methanamine and benzylamino tetrazine, respect-
ively (Fig. 19A). The two polymer solutions were mixed to form
a stable gel within 1 hour (Fig. 19B). Unreacted norbornene
groups facilitated post-gelation functionalization of the algi-
nate hydrogel with thiol-bearing molecules via a photoinitiated
thiol–ene reaction (Fig. 19C), for instance to introduce cell-
adhesive peptides. In vitro tests demonstrated the cytocompat-
Fig. 17 Functionalization of HA scaffolds. A. Crosslinking of HA with
glycidyl methacrylate via a competition between the ring opening and
transesterification mechanisms. Adapted from ref. 118. B. Preparation of
HA cryogels trough free-radical photopolymerization mediated cross-
linking with PEG diacrylate. Reprinted from ref. 119 with permission
from Elsevier, copyright (2016).
Fig. 18 Structures of Alginate and its functionalization position.
Fig. 19 A. Functionalization of alginate with tetrazine (Alg-T) and nor-
bornene groups (Alg-N) via reaction of the carboxylic acids with ben-
zylamine tetrazine and norbornene methanamine. Reprinted from ref.
128 with permission from Elsevier, copyright (2015). B. Preparation of
click alginate hydrogel via inverse electron demand Diels–Alder (IEDDA)
reaction between tetrazine and norbornene. Reprinted from ref. 126
with permission from Elsevier, copyright (2015). C. Incorporation of cell-
adhesive peptides via a photoinitiated thiol–ene reaction. Reprinted
from ref. 126 with permission from Elsevier, copyright (2015).
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ibility of the click alginate hydrogels for 2D cell culture.
Furthermore, subcutaneous injection of the hydrogel with
embedded cells in mice demonstrated its suitability for in vivo
applications.
Similar to HA, alginate is also used as a scaffold for the
development of cryogels. The biocompatibility of alginate
together with its tunable mechanical properties make alginate
a suitable scaffold for development of cryogels for delivery of
biomolecules.127,128 Mooney and coworkers prepared an algi-
nate based cryogel via a free-radical crosslinking mecha-
nism.129 To this end, methacryloyl groups were introduced in
the alginate chains via reaction of NHS-activated carboxylic
acids with 2-aminoethyl methacrylate (Fig. 20A). Macroporous
cryogels were obtained by crosslinking the MA-alginate at
subzero temperatures via free-radical polymerization
(Fig. 20B). The polymeric network of the resulting cryogel col-
lapses when subjected to shear-stress during injection but
fully recovers, which enables alginate cryogel scaffolds to be
administered through needles with almost full geometric
reconstruction.
In one example, alginate cryogels were loaded with antigen
carrying tumor cells, a dendritic cell (DC) enhancement factor
and a DC activating factor, to function as an injectable vaccine
platform (Fig. 20C).127 Subcutaneous injection of the loaded
cryogel in mice demonstrated potent and specific anti-tumor T
cell responses, indicating that alginate cryogels have a high
potential as scaffold for (cancer cell) vaccinations. To enable
injection of the alginate cryogels trough smaller needles
without breaking of the gel, Mooney and coworkers cross-
linked the alginate scaffold with Ca2+ (Fig. 20D).128 The combi-
nation of covalent (methacrylate-based free-radical polymeriz-
ation) and ionic (Ca2+) crosslinking yielded a tough cryogel
that could be injected trough a small 18G needle without sus-
taining damage.
Besides functioning as a carrier, alginate also serves as
scaffold for targeted release of active molecules. Royzen and
coworkers functionalized alginate with tetrazines for local acti-
vation of Doxorubicin (Dox), which protected by a trans-
cyclooctene (TCO) moiety can be administered systemically
(Fig. 21).131,132 Tetrazine methanamine was conjugated to the
carboxylic acids of alginate to obtain a tetrazine-functionalized
hydrogel. The high density of carboxylates on the alginate
scaffold allowed for the introduction of a large number of tet-
razine groups, which leads to high effective concentrations of
the TCO-protected molecules injected at the location of choice.
Additionally, the large number of tetrazines on the alginate
scaffold permits multiple rounds of Dox administration, and
its injectability provides a viable in vivo strategy for local acti-
vation of molecules as it does not rely on presence of mole-
cular markers or local processes. In vivo efficacy studies with
TCO-protected Dox demonstrated the excellent catch-and-
release ability of tetrazine functionalized hydrogel, validating
the use of the local activation strategy for administration of
cytotoxic drugs in vivo.
Other polysaccharides
Other semiflexible polysaccharides such as cellulose, chitin,
and chitosan (Fig. 22) can similarly function as scaffolds.
Cellulose consists of β-D-glucopyranose units linked by 1,4-gly-
cosidic bonds.133 The primary alcohols of cellulose have been
functionalized with amine ligands to prepare environmentally-
friendly regenerative catalysts for formation of C–C bonds in
organic synthesis (Fig. 23A).134 Cellulose also functioned as an
Fig. 20 A. Introduction of methacryloyl groups on alginate via acti-
vation of the carboxylic acids with NHS followed by reaction with
2-aminoethylmethacrylate (AEMA). B Preparation of injectable alginate
cryogels through free-radical polymerization mediated crosslinking of
MA-Alginate at subzero temperatures. Reprinted from ref. 129 with per-
mission from National Academy of Sciences, copyright (2012)
C. Loading of the alginate cryogels with antigen carrying tumor cells,
with dendritic cell enhancement factor CPG ODN and activation factor
GM-CSF for the development of an injectable cancer vaccine. Reprinted
from ref. 130 with permission from Nature Springer, Nature
Communications, copyright (2015) D. Preparation of an injectable tough
alginate cryogel via free-radical polymerization mediated crosslinking of
the MA-alginate and subsequent ionic crosslinking of the carboxylic
acids on the alginate chains with Ca2+ ions. Reprinted from ref. 128 with
permission from John Wiley and Sons, copyright (2018).
Fig. 21 Local activation strategy for “catch and release” of drugs.
Reproduced from ref. 131. https://pubs.acs.org/doi/10.1021/acscents-
ci.6b00150 with permission from ACS, copyright (2016). Further per-
missions related to the material excerpted should be directed to the
ACS.
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anion exchange resin to remove chromate ions from aqueous
solutions.135 To enable interaction with chromium ions, qua-
ternary ammonium groups were introduced on the scaffold via
reaction of the primary hydroxyls with succinic anhydride, fol-
lowed by conjugation of triethylenetetraamine and subsequent
reaction with methyl iodide (Fig. 23B). The resulting cellulose
scaffold effectively removed chromate from water.
Chitin and chitosan biopolymers are extensively investi-
gated for wound healing and tissue engineering appli-
cations.136 Chitin is a linear polymer of repeating N-acetyl-D-
glucosamine units. Chitosan is the deacetylated form of chitin
and consists of randomly distributed β(1,4)-linked
D-glucosamine and N-acetyl-D-glucosamine. Yang et al. conju-
gated cysteine to chitin nanofibers to prepare a material for
the removal of arsenic from aqueous solutions.137 Chitin was
deacetylated with sodium hydroxide and cysteine moieties
were conjugated on chitin nanofibers via reaction of the free
amines on chitin with the NHS-activated carboxylic acids of
cysteine (Fig. 24). The small size of the cysteine-functionalized
nanofibers gave rise to a high surface-to-volume ratio which
provided abundant sites for arsenic absorption via interaction
with the cysteine thiols. As a result, the absorption capacity of
the scaffold was higher than existing absorption systems,
attributed to multivalency, and likely to the good availability
provided by the semiflexible chitin scaffold.
Liu and coworkers modified chitosan with decanoic acid to
develop a wound dressing material that enhances wound
healing.138 Decanoic acid (DA) was conjugated to chitosan via
an NHS-mediated coupling with the amine groups of
D-glucosamine (Fig. 25A). In vivo wound healing studies in rats
with full-thickness excisional wounds showed accelerated
wound healing for gauze dressings soaked in DA functiona-
lized chitosan.
Urea groups were conjugated to a chitosan scaffold for the
development of a biomaterial with antifungal and antioxidant
applications.139 The primary hydroxyls of chitosan were chlor-
oacetyled and further conjugated with nitrogen-containing het-
erocycles. The amine groups of chitosan were reacted with
methyl iodide to form quaternary ammonium groups
Fig. 22 Structures of cellulose, chitin and chitosan and their primary
functionalization positions.
Fig. 23 A. Introduction of amine ligands via tosylation of the primary
hydroxyls on the cellulose chain followed by a substitution reaction with
the amine ligand and subsequent coordination with Palladium (Pd
(OAc)2) to afford a regenerative catalyst for the formation of C–C bonds.
Reprinted from ref. 134 with permission from Elsevier, copyright
(2019). B. Functionalization of the cellulose scaffold with quaternary
ammonium groups via reaction of the primary hydroxyls with succinic
anhydride, followed by conjugation of triethylenetetraamine and sub-
sequent reaction with methyl iodide. Reprinted from ref. 135 with per-
mission from Elsevier, copyright (2009).
Fig. 24 Conjugation of cysteine moieties on deacetylated chitin
nanofibers. Reprinted from ref. 137 with permission from Elsevier,
copyright (2015).
Fig. 25 Functionalization of chitosan scaffolds. A. Introduction of
decanoic acid (DA) via NHS activation of the carboxylic acid of DA fol-
lowed by reaction with the amine groups of chitosan. Reprinted from
ref. 138 with permission from Elsevier, copyright (2019). B. Conjugation
of urea compounds to the chitosan scaffold via chloroacetylation of the
primary hydroxyls on the chitosan chain with 2-choroacetyl chloride fol-
lowed by conjugation of the urea compounds through reaction with the
nitrogen of the heterocyclic urea compounds. Reprinted from ref. 120
with permission from Elsevier, copyright (2019).
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(Fig. 25B), which improved its water solubility. The functiona-
lized chitosan scaffold showed increased antifungal and anti-
oxidant activities in comparison with chitosan.
Overall, the functionalization of polysaccharides primarily
occurs at the available functional groups of the backbone,
quite similar to collagen derivatization. Polysaccharides,
however offer the advantage that the density and variety of
these groups is very high, giving access high loading
capacities. The downside of this class of semi-flexible polymers
is the poor spatial control, unless the chain-end is specifically
targeted.
Synthetic polymers
Despite the rapidly increasing efforts in the field, semiflexibil-
ity in synthetic polymers remain a rare find. In contrast to
semiflexible biopolymers, synthetic polymers provide more
strategies to introduce substituents. Monomer modification
and post-functionalization approaches allow grafting of substi-
tuents on polymer chains to give rise to well-defined polymer
scaffolds. In the following sections, we will review common
conjugation approaches of some of the major classes of syn-
thetic semiflexible polymers, including synthetic polypeptides,
conducting polymers and polyisocyanides. Moreover, we
include applications of the grafts in biosensing, bioimaging,
drug delivery, optoelectronics, photovoltaics and tissue
engineering.140–145
Synthetic polypeptides
The amino acid building blocks that comprise synthetic poly-
peptide scaffolds retain various functional handles that enable
the introduction of virtually any substituent. Amine, carboxyl,
hydroxyl and thiol functional groups on amino acids can be
utilized for conjugation strategies with functional molecules.
Typically, synthetic polypeptides are prepared via SPPS or
ring opening polymerization (ROP) of α-amino acid
N-carboxyanhydrides (NCAs). SPPS is generally used to
produce oligopeptides whereas ROP enables the synthesis of
polypeptides with high molecular weights.146 NCA monomers
are conveniently synthesized in large scales from the corres-
ponding α-amino acids147 and living polymerization tech-
niques yield polypeptides with low polydispersity (PDI) and
allow for the controlled incorporation of multiple amino
acids.148,149 The use of (orthogonal) protection strategies
allows for subsequent conjugation of substituents to amino
acid side chains at specific positions along the polymer chain,
resulting in a well-defined scaffold. Additionally, aminolysis-
based chemoenzymatic polymerizations of peptides have been
reported but reaching high molecular weights and good
sequence control remains challenging.150
Many functional molecules have been introduced on the
synthetic polypeptide backbone, including crosslinks, fluo-
rescent dyes or binding sites for drug delivery.151–153
Frequently, the applied functionalization strategies follow
unselective post-polymerization conjugations, analogous to
what is described in the biopolymer section of this review.
Here, we will zoom in on alternative strategies that employ the
polymerization reaction or use monomer modification to
introduce substituents.
The Pochan group used SPPS to develop small computa-
tionally designed chains that assemble into well-defined semi-
flexible tetrameric bundles (bundlemers).154 A Michael
addition of the maleimide groups at the N-terminus with a
thiol functionalized linker yields co-polymer chains (Fig. 26A).
The introduction of functional handles in the peptide chain
enables further conjugation with substituents in any desired
pattern. Pouchan functionalized the peptide chains with an
alkyne handle to conjugate azide-terminated PEG polymers to
the polypeptide, producing polymer chains with a regular
nanometer scale pattern (Fig. 26B), which they confirmed with
atomic force microscopy studies.
ROP has been applied to develop homopolypeptide
scaffolds that can be functionalized post-polymerization. Anas
et al. prepared alkyne functionalized poly(cysteine) via NCA
polymerization, to which they grafted azide-containing
polymer chains to generate self-assembling vesicles.155 A poly
(glutamic acid) scaffold bearing furan side chains was devel-
oped via the same strategy, which is compatible with conju-
gation of maleimide-modified Dox via a Diels–Alder reac-
tion.156 Deming and coworkers synthesized polypeptides with
N-methylaminooxy groups via ROP to enable conjugation of
unmodified sugars (Fig. 26C).157
The synthesis of neoglycopolypeptides that mimic glyco-
proteins is often laborious, as it requires multistep monomer
synthesis and the use of protecting groups. Development of a
polypeptide scaffold that allows post modification with un-
modified sugars enables the synthesis of neoglycopolypeptides
in a facile, versatile manner. To this end, NCA monomers car-
rying an aminooxy handle were developed from L-methionine
(Fig. 26C) after deprotection of the thiol group followed by a
substitution reaction with 2-(N-Boc-N-methylaminooxy)ethyl
bromide and subsequent conversion into the NCA monomer
Fig. 26 A. Michael addition of the maleimide-functionalized peptide
bundlemers with a thiol functionalized linker to afford a semiflexible
polymer chain. Adapted from ref. 154. B. Single letter code and sche-
matic presentation of peptide bundlemers and their assembly. Reprinted
from ref. 154 with permission from Nature Springer, Nature, copyright
(2019). C. Synthesis of NCA monomer (left) and conjugation of
D-glucose to polypeptide scaffold (right). Reprinted from ref. 157 with
permission from American Chemical Society, copyright (2019).
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using phosgene. ROP polymerization followed by Boc-de-
protection yielded N-methylaminooxy functionalized homopo-
lypeptide chains. These peptide scaffolds were conjugated with
a variety of mono- and disaccharides in high yields, which
makes them attractive for development of glycoprotein
mimics. The straightforward synthesis and functionalization
of the polypeptide chain demonstrates its versatility as a
scaffold.
Copolymerization techniques broaden the potential of poly-
peptide scaffolds by enabling the spatially controlled introduc-
tion of substituents along the polymer backbone. The group of
Lei incorporated catechol (DOPA) on a polypeptide scaffold to
prepare copolymer glues as surgical adhesives.158 Various poly-
peptide–Pluronic–polypeptide block-copolymers were syn-
thesized through ROP of L-DOPA-N-carboxyanhydride with
L-arginine-NCA, L-cysteine-NCA, or ε-N-acryloyl lysine-NCA
(Fig. 27A). The polymerization reaction was initiated by
Pluronic-L31, a thermo-responsive polymer that ensures gela-
tion of the copolymer in aqueous solution under physiological
conditions. The pendant catechol groups on L-DOPA form
(non)covalent bonds with various substrates. Via this mecha-
nism, L-DOPA can form homo-crosslinks or with the alkyne or
thiol groups of cysteine and lysine units via a Michael type
addition (Fig. 27B). The guanidinium ions on the scaffold
form salt bridges with a protein surface, which together with
the catechol-substrate interactions gives attachment of the
polymer to skin (Fig. 27B). In vivo application of the copolymer
solutions demonstrated its efficiency in the wound healing
process, highlighting that polymerization of functionalized
NCAs is an excellent strategy to introduce substituents on a
polypeptide scaffold.
In addition, ROP-synthesized polypeptide copolymers with
structure poly(lysine)x(alanine)y were crosslinked with 6-arm
PEG-glutarate-NHS via amide bond formation with the amino
groups of the lysine units.159 This crosslinking reaction
afforded hydrogels with significant cell adhesion, proliferation
and antibacterial activities that can function as scaffolds
for wound healing applications. A similar method was
applied to crosslink the glutamic acid units on PEG-poly
(glutamine)x(phenyl alanine)y block co-polymers.
160 The three
blocks in the polymer chain form multi-compartment micelles
that enable co-delivery of hydrophilic and hydrophobic anti-
cancer drugs. Crosslinking of the glutarate carboxylic acids with
1,2-ethylenediamine stabilizes the micelle towards proteases.
Nucleophiles such as amines can initiate ROP and are, as
such, readily introduced at one chain end of polypeptide
scaffolds. This method is extensively applied to introduce
alkyne or azide handles, fluorescent dyes, nanodiamonds and
a wide variety of polymer chains.161–167 Wei and coworkers
applied this strategy to develop amphiphilic poly(amino acid)s
that self-assemble into luminescent polymer nanoparticles
(LPNs) starting from a amine containing aggregation induced
emission dye to polymerize OEG-functionalized glutamate
(OEG-glu) NCA.163 The resulting dye functionalized polygluta-
mate scaffolds (dye-OEG-Pglu) formed LPNs in aqueous solu-
tion with the hydrophobic dye aggregated in the core while the
hydrophilic OEG chains functioned as a shell. The LPNs
exhibited efficient luminescence and were potent for cell
imaging applications. Initiating polymerization with the dye
ensured its position on the polymer chain end, which resulted
in a scaffold with desired amphiphilic properties for LPN for-
mation. Dong and coworkers exploited a similar method to
prepare amphiphilic block copolymers that form micelles and
can function as light responsive drug carriers.168 ROP of photo
responsive S-(o-nitrobenzyl)-L-cysteine (NBC) NCA monomers
was initiated by amine-functionalized poly(ethylene glycol)
(PEG). The resulting micelles were loaded with Dox. Cleavage
of the photosensitive nitrobenzyl moiety by UV irradiation
resulted in controlled release of Dox from the micelles as the
hydrophobic binding interactions between Dox and nitro-
benzyl reduced after cleavage. Although functionalization of a
scaffold via ROP initiation is an efficient strategy for the intro-
duction of substituents in a controlled manner, its versatility
remains limited as functional groups can only be introduced
at one chain end.
Polypeptides offer many advantages, including high versati-
lity and availability of the building blocks. While (NCA)
monomer modification followed by ROP or SPPS and post
functionalization are great techniques to functionalize poly-
peptide scaffolds with high functional group densities, ROP
initiation is very useful for development of amphiphilic poly-
peptides. SPPS offers sequence control and with that high
spatial control. Through chain extension strategies, also longer
peptide polymers are within reach.
Fig. 27 A. Synthesis of PPDA (from L-arginine NCA), PPDAC (from
L-cysteine NCA) and PPDAL (from ε-N-acryloyl lysine-NCA) polypep-
tides. Reprinted from ref. 158 with permission from American Chemical
Society, copyright (2017). B. Schematic representation of polymer inter-
actions with skin substrate. Reprinted from ref. 158 with permission
from American Chemical Society, copyright (2017).
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Conducting polymers combine useful properties of both
organic molecules and semiconductors and have formed a
mature research field over the past decades. Many polymers,
however are intrinsically rigid and poorly processable.169
Introduction of substituents adds flexibility to the rigid back-
bone of conducting polymers, which improves their processa-
bility and provides opportunity to add more functionality to
the scaffolds.170
Polyacetylene (PA), polyaniline and polypyrrole are semiflex-
ible conducting polymers that have been functionalized for the
development of various electric devices and chemical sensors.
Substituted polythiophenes are considered more flexible.171
Functionalization strategies for polythiophenes have been
reviewed earlier.172
Polyacetylene
Research on unfunctionalized PA (Fig. 28A) stagnated due to a
lack in processability and stability.173 Functionalized PAs,
however remain soluble in many solvents and are stable in air
for a long period of time, which makes these polymers easier
to handle.173 The carbon–carbon alternating double bonds in
the PA backbone contribute to a variety of properties such as
conductivity, gas permeability, and photo- and electrolumines-
cence.173 These findings induced a regained interest PAs and
their applications as a scaffold. A variety of transition metal
catalysts have been used to form functionalized PAs via the
insertion or metathesis polymerization mechanisms.
Currently, Rh-based catalysts are used most frequently as they
enable living polymerization and the synthesis of well-defined
PA (block co)polymers with high initiator efficiency.174 Due to
the insolubility of unsubstituted PAs, post-polymerization
functionalization is not feasible. Therefore, substituents are
generally introduced via modification of acetylene monomers.
One or two substituents can be placed on each repeating unit
in the chain. In this review, we highlight a number of examples
of substituted polyacetylenes, in which the polyacetylene back-
bone functions as a clear scaffold. We refer the reader to an
extensive overview on substituted polyacetylenes for more
information.174
Monosubstituted acetylene polymers are readily synthesized
through direct polymerization,175 which tolerates a wide
variety functional groups, different polarities and a substantial
bulkiness.176–182 An example of such monosubstituted PA
scaffold was prepared by Masuda and coworkers, who functio-
nalized PA with 2,2,6,6-tetramethyl-1-piperidinoxy (TEMPO,
Fig. 28B) radicals to develop organic radical batteries.183
Oxidation of the nitroxy group of TEMPO to form an oxo-
ammonium cation is reversible and this process can be used
to develop cathode active materials. PA is a particularly suit-
able scaffold due to its semiconductive properties and the for-
mation of a rigid scaffold. The direct polymerization method
ensures quantitative incorporation of the TEMPO groups on
the scaffold for optimal charging and discharging.
Most disubstituted PAs cannot be synthesized via direct
polymerization of their monomers due to deactivation of the
catalyst by active protons or coordinative ligands in the mono-
mers.175 Tang and coworkers developed a strategy that allows
introduction of a second substituent after polymerization.184
An acetylene monomer with a phenyl substituent and a chlor-
ine handle was polymerized and subsequently functionalized
with imidazole via nucleophilic substitution of the chlorine
(Fig. 28C). The resulting disubstituted scaffold could function
as a chemosensor for Cu2+ and CN− through quenching or
recovery of the fluorescent signal of the PA scaffold. These
results show that incorporation of an active handle such as
chlorine on a polyacetylene scaffold facilitates post-polymeriz-
ation functionalization and provides a versatile strategy to
develop multiple disubstituted polyacetylene materials.
Polyaniline
Over the past few decades, polyaniline (PANI, Fig. 29A) has
materialized as a key conducting polymer for commercial
applications.185 Its easy synthesis, stability and controlled elec-
trical properties make PANI an attractive functional
scaffold.186,187 Conventional methods to synthesize PANI
chains include chemical or electrochemical oxidative polymer-
ization of aniline.188 Despite the facile synthesis, both
methods result in inconsistent PANI products instead of the
desired nanofibrillar morphology.189 Alternatively, interfacial
synthesis of PANI allows spontaneous reaction between aniline
and an oxidant such as ammonium peroxydisulfate at the
interface between two immiscible solvents. This method
results in the formation of PANI nanofibers with uniform dia-
meters between 30 and 50 nm and lengths up to micrometer
scale.190 Although PANI synthesis is experimentally easy, its
Fig. 28 A. Structure of PA. B. Schematic overview of the synthesis of
TEMPO substituted acetylene monomers and subsequent polymeriz-
ation. Reprinted from ref. 183 with permission from John Wiley and
Sons, copyright (2007). C. Synthesis of disubstituted PA and post
functionalization of the PA scaffold with imidazole (left). Schematic
overview of the probe, where interaction with Cu2+ quenches the fluor-
escent signal and subsequent interaction with CN− restores the fluor-
escence (right). Reproduced from ref. 184 with permission from the
Royal Society of Chemistry, copyright (2008).
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polymerization mechanism is intricate; for detailed infor-
mation, we refer to a review.187
PANI can be functionalized via modification of aniline or via
post-polymerization modification. Direct introduction of substi-
tuents on the aniline monomer can induce steric challenges
during the polymerization with the possibility that the conduct-
ing properties of the scaffold are compromised.191 As such,
surface modification is frequently used as a post-polymerization
functionalization strategy for PANI nanofiber functionali-
zation.192 Surface modification allows covalent attachment of
functional groups via nucleophilic addition to the quinoid ring
of the PANI backbone.191,193 The Hanks group applied surface
modification to introduce thiol-terminated PEG on PANI nano-
structures to improve PANI water solubility (Fig. 29B).194 Thiols
react efficiently with PANI to change the polymers’ surface pro-
perties without affecting its conductivity. The authors found
that the degree of PEG-SH substitution increases with tempera-
ture, which in turn increases solubility and promoted further
access to the PANI scaffold. This effect was used to control the
PEG coverage of the PANI scaffolds. The prepared PEGylated
polyaniline polymers were water dispersible and maintained
their original morphology and electroactivity, showcasing that
this approach is a suitable technique to modify polyaniline
scaffolds in a controlled manner and without disrupting the
properties of polyaniline.
O’Kennedy and coworkers used a similar surface modifi-
cation technique to immobilize antibodies on polyaniline
nanofibers for the development of immunosensors.195 PANI
nanofibers were prepared via interfacial polymerization and
subsequently modified with mercaptoundecanoic acid, mer-
captopropionic acid or cysteamine via employing the reactivity
of the thiol nucleophiles.193,196 IgG antibodies were conjugated
to both carboxyl and amino functionalized nanofibers via
ethyl diaminocarbodiimide (EDC) chemistry to form amide
bonds (Fig. 29C). Cyclic voltammetry experiments showed
direct electrical communication between the polyaniline nano-
fibers and the covalently linked peroxidase-linked antibodies,
which forms the working mechanism of the antibody conju-
gated PANI scaffolds as immunosensors. Furthermore, the
amino and carboxylate functionalized polyaniline polymers
provide versatile scaffolds for further derivatization.
Analogous to previous examples, Gangopadhyay et al.
applied interfacial polymerization to incorporate gold nano-
particles on PANI nanowires for biosensing applications,140
where the electrical properties of PANI change upon bio-
molecule binding. To this end, the gold nanoparticle (AuNP)
functionalized PANI nanowires were deposited on a platinum
electrode and the gold was functionalized with
β-mercaptoethylamine (Fig. 29D). The introduced primary
amine facilitates attachment of a variety of biomolecules. An
oligonucleotide (dA) was conjugated to the electrode to
monitor its hybridization and thus sensing ability of a target
nucleotide (dT) (Fig. 29D). Hybridization with the target
nucleotide at a minimal concentration (10−18 M) led to peak
current values and changes in impedance, demonstrating the
extreme sensitivity of the sensing platform. The AuNP-functio-
nalized PANI nanowires on the electrode facilitate introduction
of various functional groups, which enables binding to a
variety of biomolecules and thus generates a multifunctional
biosensing platform.
Polypyrrole
Because of its easy synthesis, high conductivity and stability in
the oxidized state, the interest in polypyrrole (PPy, Fig. 30A)
remains high.197 PPy is readily obtained by electrochemical198
or oxidative199 polymerization of pyrrole. For both methods
holds that controlling the oxidation potential of the reaction
mixture increases the conductivity of the synthesized polymers
and results in the formation of polypyrrole with a homo-
genous, fibril-like surface morphology.199,200
Substituents are introduced on the polypyrrole scaffold via
the direct modification of the pyrrole monomer or via the intro-
duction of a handle on pyrrole followed by post-polymerization
functionalization. Bidan and coworkers synthesized homopoly-
mer biotin-functionalized PPy sensors by polymerizing biotin-
modified pyrrole (Fig. 30B).201 After avidin treatment of the de-
posited polymer, the layer serves as an electrode that can
immobilize biotinylated enzymes or oligonucleotides.202
Lee and Schmidt prepared amine functionalized pyrrole
scaffolds via a similar method.203 Aminopropyl-modified
pyrrole was polymerized via electrochemical polymerization
with and without pristine pyrrole to afford homo- and copoly-
mers (Fig. 30C). In line with earlier work,204,205 the authors
found that modified pyrrole is poorly incorporated, likely due
to increased steric interactions. Introduction of positive
Fig. 29 A. Structures of PANI, from top to bottom; leucoemeraldine
(reduced), emeraldine (partly oxidized) and pernigraniline (fully
oxidized). B. Reaction mechanism of surface modification of PANI nano-
structures with thiol compounds. Adapted from ref. 194. C. Schematic
overview of the preparation of an antibody sensor: (i) introduction of
amine or carboxylic acid handles via surface modification; (ii) conju-
gation of antibodies through EDC-mediated reactions; (iii) detection of
secondary antibody, labeled with horseradish peroxidase (HRP).
Reprinted from ref. 186 with permission from Elsevier, copyright
(2011). D. Schematic overview of the synthesis of a DNA probe:
functionalization of Pt/PANI-Au-NP with β-mercaptoethylamine, fol-
lowed by conjugation of oligonucleotides (dA) and detection of target
nucleotides (dT). dTs were detected via cyclic voltammetry (DPV).
Reprinted from ref. 140 with permission from Elsevier, copyright (2012).
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charges on PPy by introducing amine groups resulted in a
scaffold that improved adhesion of fibroblasts and Schwann
cells and shows promise as a substrate for cell culture appli-
cations. Schmidt and coworkers used the same monomer
modification strategy to develop carboxylic acid functionalized
PPy scaffolds.204 The cyano group in 1-(2-cyanoethyl)pyrrole
was hydrolyzed to a carboxylic acid using KOH and HCl to
afford 1-(2-carboxyethyl)pyrrole which was subsequently poly-
merized to afford a carboxylic acid-functionalized pyrrole
homopolymer (Fig. 30C). Via a similar monomer modification
strategy, PPy scaffolds were synthesized from NHS-functiona-
lized pyrrole monomers (Fig. 30D).206 Such amine-, carboxylic
acid-, and NHS-functionalized polypyrroles have been used as
a scaffold for post-functionalization with oligonucleotides,
peptides or electrochemical probes.205–207
As steric hindrance of bulky pendants interferes with
polymerization, direct monomer modification is not always
advantageous. Post polymerization functionalization circum-
vents such limitations. Wang et al. applied this strategy to con-
jugate porphyrins on a polypyrrole-like scaffold.208 4-[Di(1H-
pyrrol-2-yl)methyl]phenol monomers were polymerized using
ammonium perchlorate as oxidant. Next, the scaffold was
functionalized (Fig. 30E) with porphyrins covalently (via a
straightforward substitution reaction) and/or noncovalently
(through coordination to the metal inside the porphyrin ring).
Charge transfer interactions between the porphyrins and the
conducting polymer scaffold gives rise to unique electrooptical
properties.
To facilitate spatially controlled introduction of substitu-
ents, PPy scaffolds can be capped with a functionalized pyrrole
monomer via electrochemical coupling. The group of Schmidt
applied this method to prepare a carboxylic acid end-capped
PPy scaffold that was used for the conjugation of the cell-
adhesive tripeptide arginylglycylaspartic acid (RGD in single
letter code) to develop a cell culture scaffold.209 PPy was elec-
trochemically synthesized on an electrode. The resulting films
were modified with a carboxylic acid functionalized pyrrole via
a final electrochemical coupling and were subsequently deco-
rated with RGD-peptides through sulfo-NHS and EDC chem-
istry (Fig. 30F). The selective introduction of the carboxylic
acid handle at the chain end of PPy gives rise to a well-defined
scaffold structure without compromising electrical conduc-
tivity and mechanical integrity. Jang et al. applied an equi-
valent strategy, albeit with a pyrrole monomer already with the
RGD peptide attached. Electrochemical introduction of the
functional monomer was controlled by the deposition time.210
Analogous to initiator modification, electrochemical coup-
ling facilitates scaffold functionalization with high spatial
control, but its application remains limited as it only allows
introduction at the polymer chain end.
Polyisocyanides
We end this review with a class of polymers named polyisocya-
nides, which is one of the largest classes of synthetic semiflex-
ible polymers. Although known from the 1970s, recent devel-
opments moved these polymers to the forefront of various bio-
medical applications. Because of the extensive research in the
field, we divided poly(isocyanides) (PICs) further into poly(iso-
cyanopeptides) (PICPs) and water soluble PICPs.
Poly(isocyanides)
Similar to many bio-macromolecules, semiflexible PICs
possess a helical conformation211 as a result of the polymeriz-
ation process (Fig. 31A).212,213 The most common methods to
prepare PIC involve transition metal complexes of Ni(II), Pd(II)–
Pt(II) or Rh(III).214 The steric demands of each carbon in the
polymer backbone bearing a substituent restricts rotation of
the single bonds in the backbone, which stabilizes the helical
structure. This stable helical conformation makes PIC poly-
mers suitable building blocks for development of chiral macro-
molecules or compounds that mimic bio-macromolecules.
Fig. 30 A. Structure of PPy. B. Synthetic route towards biotin functio-
nalized pyrrole. Adapted from ref. 202. C. Synthetic route towards amine
and COOH functionalized pyrrole monomers and subsequent polymer-
ization of pristine and functionalized pyrrole. Adapted from ref. 203 and
204. D. Synthetic route towards NHS-functionalized pyrrole. Adapted
from ref. 206. E. Overview of PPy functionalization with porphyrin (TTP)
via metal coordination (SnTPP-PPy) and a combination of covalent and
coordination (TPP-PPy-SnTPP). Reproduced from ref. 209 with per-
mission from the Royal Society of Chemistry, copyright
(2019). F. Synthetic route towards RGD capped PPy. Reprinted from ref.
209 with permission from American Chemical Society, copyright (2006).
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The preserved helical conformation of PICs provides an
excellent scaffold to develop highly ordered materials with
applications in optoelectronics, photonics, memory devices
and cell imaging.143,215–217 Isocyanide monomers are readily
obtained via dehydration of the corresponding formamides.
Substituents are introduced on PIC scaffolds via direct modifi-
cation of the isocyanide monomer or by introduction of an
active handle targeted towards post-polymerization
functionalization.
Takei et al. modified isocyanide monomers to prepare
arrays of porphyrins for development of light-harvesting
systems.218 Aryl-isocyanide monomers with porphyrin pen-
dants were prepared via the introduction of a nitrite, which
was reduced to an amino-group followed by formylation and
dehydration into an isocyanide. The monomers were polymer-
ized to give precisely stacked porphyrin arrays. The porphyrin
bulkiness combined with π–π stacking of adjacent aryl moi-
eties in the side-chains further stabilized the helical confor-
mation and the well-defined arrangement of the porphyrins in
the stacks. Various chiral groups, chromophores, fulvenyl moi-
eties, metal complexes, perylenes and saccharides have been
introduced on poly(aryl isocyanide) scaffolds using the same
monomer modification strategy.216,219–223 Direct monomer
modification has also been applied to introduce carbazoles
and a variety of bulky pendants on poly(isocyanide)
chains.143,224
Although polymerization of modified monomers is a suc-
cessful strategy to prepare functionalized PIC scaffolds with
high spatial control, it is not a versatile strategy as introduction
of a new substituent requires a completely new monomer syn-
thesis and consecutive polymerization. Decoration of the PIC
scaffold with handles such as azido, alkyne or thiol groups
allows for post-polymerization functionalization, which
enables facile derivatization of the scaffold towards multiple
purposes. The Weck group integrated a terminal alkyne handle
on PIC via modification of the nickel(II) catalyst (Fig. 31B).225
This approach enables coupling of the polymer scaffold to a
variety of substituents such as dyes or other polymers to gene-
rate (block) copolymers.222,226,227 While the introduction of a
handle via initiator modification is an elegant functionali-
zation strategy, its applications are restricted, analogous to
electrochemical coupling and ROP initiator modification men-
tioned earlier.
A method to enable post-functionalization of the full PIC
scaffold was develop by Wu and coworkers217 who incorpor-
ated a pentafluorophenyl (PFP) ester on the PIC side chains,
which provided a handle for covalent crosslinking.
Amphiphilic block-copolymers were synthesized through one-
pot sequential polymerization of PFP-functionalized phenyl
isocyanide monomers (Fig. 32, M1), tetraphenylethene-functio-
nalized phenyl isocyanide monomers (M2) and hydrophilic
phenyl isocyanide monomers (M3). PFP proved to be an
efficient handle for post polymerization functionalization and
subsequent micelle formation. In later work, it has been used
to introduce a variety of molecules such as pyrene and PEG
chains.228,229
Poly(isocyanopeptides)
Nolte and co-workers demonstrated that two or three amino
acids directly substituted to the isocyanide strongly stabilize
the helical conformation via the formation of a network of
intramolecular hydrogen bonds between the amide groups of
the nth and (n + 4)th side chains (Fig. 33A).230–233 This discovery
Fig. 32 Synthetic route for the successive copolymerization of pen-
tafluorophenyl-, tetraphenylethene-, and hydrophilic phenyl PICs
(PFPPI-TPEPI-HPPI-HPPI-polymers) (left). Schematic representation of
micelle formation and subsequent luminescent behavior and reducing
agent triggered payload release. Reprinted from ref. 197 with permission
from American Chemical Society, copyright (2017).
Fig. 31 A. Formation of stable helix by polymerizing tert-butylisocya-
nide with a nickel(II) catalyst. Reproduced from ref. 214 with permission
from the Royal Society of Chemistry, copyright (2011). B. Isocyanide
polymerization with an alkyne-modified nickel(II) catalyst to introduce
an alkyne handle on the polymer chain-end. Reprinted from ref. 225
with permission from John Wiley and Sons, copyright (1969).
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gave rise to the formation of a subclass of poly(isocyanides)
termed poly(isocyanopeptides) (PICPs) and circumvented the
use of bulky substituents on the isocyanide. The stable helical
structure of the polymer chain introduces an increased persist-
ence length,234 thereby facilitating the arrangement of substi-
tuents in well-defined arrays, which is favorable for develop-
ment of functional materials in the field of photonics and
electronics.235
Substituents such as carbazoles, perylenes, porphyrins and
thiophenes were introduced on a PICP scaffold via the
monomer modification strategy previously described in this
paragraph.215,236–238 The well-defined alignment of perylenes
along the polymer backbone resulted in overlapping pathways
along which excitons and electrons rapidly migrate, showing
potential application in the field of optoelectronics and
photovoltaics.144,215,239
While monomer modification yields full substitution of the
backbone, monomer synthesis is laborious and requires
optimization of polymerization conditions for each monomer.
To overcome this disadvantage, monomers carrying an acetyl-
ene group were incorporated on the polymer chain to provide
handles for post-functionalization via click-chemistry.240
Researchers demonstrated that this route allows the introduc-
tion of perylenes, phthalocyanines and OEG substituents
(Fig. 33B).235,241
Nolte’s group prepared PICPs bearing an alanine-cysteine
motif in the side chain to develop a versatile scaffold for post-
polymerization conjugation of various active molecules via
reaction with the thiol (Fig. 33C).242 Thiol-maleimide click
chemistry between the scaffold and maleimide functionalized
pyrenes resulted in a well-defined arrangement of chromo-
phores. To demonstrate the versatility of the PICP scaffold,
pyrene derivatives bearing different thiol-click substrates were
conjugated. Similarly, the iodoacetamide- and thioester-modi-
fied pyrenes were efficiently conjugated to the scaffold and
formed well-defined arrangements. With these results, the
researchers show that incorporation of cysteines on the PICP
side-chains provides a versatile scaffold for the highly efficient
introduction of substituents. Additionally, Nolte and co-
workers decorated the side chains with OEG tails to improve
polymer solubility in water while retaining the helical
conformation.242
Water-soluble poly(isocyanopeptides)
For polyisocyanides to enter the biomedical field, water-
soluble derivatives have been prepared. Kitto et al. conjugated
azido functionalized OEG chains to acetylene bearing PICPs
thrugh the efficient CuAAC click reaction.235 The post-
functionalization, however led to a change in the helical con-
formation of the polymer. The alternative route, i.e. modifi-
cation of the isocyanopeptide monomers with OEG tails fol-
lowed by polymerization gave rise to water-soluble poly(isocya-
nopeptides) (wsPCIPs) that retained their stable helical confor-
mation.243 This subclass of PICs have become one of the domi-
nating examples of synthetic semiflexible polymers over the
course of a few years. Aqueous solutions of the wsPICPs show
a lower critical solution temperature and, reversibly, form gels
upon heating.244 The gelation temperature Tgel depends on the
environment245 as well as the exact molecular design and can
be finetuned by the molecular weight,245 the peptides246 and,
most strongly, by the length of the oligo(ethylene glycol)
tail.247 In the next section, we will discuss the two workhorses
of the family, the tri(ethylene glycol)PICP with Tgel ∼ 18 °C
(gel at 37 °C) and the tetra(ethylene glycol)PICP with Tgel ∼
40 °C (soluble at 37 °C) sequentially (Fig. 34A).
The hydrogels formed by tri(ethylene glycol)PICP display a
fibrous structure,248 quite similar to gels made of biopolymers
such as collagen, actin and intermediate filaments. Not only
the semiflexible architecture is similar, also the mechanical
properties closely mimic those of the biogels, including a
strong strain-stiffening response, i.e. an increase in the
stiffness (sometime 100-fold) upon small deformations of the
gel244,249,250 even under complex multiaxial deformations.251
The gels have been used extensively as functional soft scaffolds
in a wide range of applications. Wagener and colleagues
demonstrated its use as a washable dressing for abdominal
wounds.252,253 Yang and coworkers developed an injectable (at
5 °C) and in situ gel forming composite with Lipoxin A4-con-
taining poly(lactic-co-glycolic acid) (PLGA) microparticles and
found sustained release in treatment against periodontitis in
animal studies.254,255 Xing and coworkers used the scaffolding
capacity of the PICP backbone to induce conformational
changes in water-soluble conducting polymers (polythio-
phenes and polyfluorenes).256–258 The stretched conformations
Fig. 33 A. Schematic representation of the hydrogen bonding network
between the pendant alanine units and 41 helical conformation of PICs/
PICPs. Reprinted from ref. 242 with permission from John Wiley and
Sons, copyright (2010). B. Post-functionalization of PICPs bearing acety-
lene groups via CuAAC reaction from azide-pendant
monomers. C. Post-modification of PICPs through conjugation of sub-
stituents with the thiol groups in the side chains. Reprinted from ref. 242
with permission from John Wiley and Sons, copyright (2010).
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Fig. 34 A. Schematic structure of a (fictional) wsPICP comprising tri(ethylene glycol), tetra(ethylene glycol) and azido-tetra(ethylene glycol) side
chains, respectively. B. Conjugation of BCN to GRGDS peptide and functionalization of a wsPICP scaffold with GRGDS via the SPAAC reaction.
Reprinted from ref. 263 with permission from Nature Springer, Nature Materials, copyright (2015). C. Overview of the preparation of DNA-responsive
wsPICP hydrogels (up, left) with the pH or thrombin dependent contraction and expansion motifs in the crosslinker. Copied from ref. 275. https://
pubs.acs.org/doi/abs/10.1021/acs.biomac.7b00964. Reprinted with permission from ACS, copyright (2017). Further permissions related to the
material excerpted should be directed to the ACS. D. Schematic overview of post-functionalization of a wsPICP scaffold with anti-CD3 and anti-
CD28 via the SPAAC reaction between BCN-Sav and the azide handles on the scaffold followed by introduction of anti-CD3 and anti-CD28 through
biotin-Sav coupling. Reprinted from ref. 278 with permission from American Chemical Society, copyright (2015). E. Schematic representation of the
grafting block-copolymers (PIC brushes) containing allyl and azide handles through ‘SPAAC first’ or ‘graft first’ strategies and biotin-based grafting
route to generate PICP-brushes through the NITEC reaction (below) that can be grafted to Sav surfaces. Copied from ref. 281. https://pubs.acs.org/
doi/10.1021/acs.biomac.9b00385. Reprinted with permission from ACS, copyright (2019). Further permissions related to the material excerpted
should be directed to the ACS.
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red shifts the absorption band of the polymers, which allows
the formation of reactive oxygen species (ROS) after
irradiation with red light. The hydride forms an efficient
photodynamic antimicrobial material with activity towards
various pathogens. The efficiency further increases after the
addition of nanoparticles which introduce also a thermal
component.257 More in general, the addition of a second
component, either particle or polymeric, is an efficient route
towards responsive synergistic properties.259,260 For instance,
the addition of poly(N-isopropylacrylamide) (PNIAPM) gives
rise to a strong thermal stiffening response that can be opti-
mized to a 10 fold increase in stiffness with a mere 1 °C
increase in temperature.261
To benefit from the unique biomimetic properties of
wsPICPs for cell culture applications, the scaffold usually
requires functionalization with a cell-adhesive peptide; the
most frequently used contain RGD. To this end, a monomer
with a terminal azide handle is randomly copolymerized with
the non-functional monomer.262 Peptides, equipped with a
DBCO or BCN group are then cleanly introduced via a SPAAC
reaction, resulting in a biofunctional and biomimetic scaffold
(Fig. 34B).262,263 The materials have been used in a number of
in vitro 3D cell culture studies, where the readily controlled
(mechanical) properties were used to tailor cell behavior, for
instance towards stem cell differentiation263,264 and secretome
modification,265 cancer therapy,266 morphogenesis,267 orga-
noid formation,268,269 vascularization270 and T-cell
expansion.271
Using the same SPAAC approach other functional groups,
such as dyes248 or PET probes253 have been introduced. To
tune the mechanical behavior and the thermal response of the
wsPICPs, crosslinks were introduced via the same SPAAC
approach. Whereas simple bifunctional covalent crosslinks
were shown to merely stabilize the gel,272 the use of multi-
functional capsid-based crosslinkers introduces a healing
mechanism after mechanical damage as well as a mechanical-
induced payload release system.273
Tetra(ethylene glycol)-decorated wsPICP also forms gels
when crosslinkers are introduced at the azide handles of the
polymers. Deshpande et al. used DNA-based linkers to gene-
rate highly stimulus-responsive hydrogels.274 DNA strands A
and B were functionalized with DBCO and clicked to the azide-
decorated polymer to give wsPICPs-DNA A and wsPCIP-DNA-B
(Fig. 34C). DNA strand C that is complementary to A and B
forms the crosslinks, which generates a hydrogel below Tgel,
which (nonlinear mechanical) properties are customizable by
varying the crosslinker C to A/B ratio. A pH-responsive element
or thrombin binding DNA sequence into crosslinker C intro-
duces further response motifs to gel.275 The advantages of this
approach has been demonstrated in DNA functionalized
PNIPAM nanogels in the context of controlled Dox release.276
Furthermore, Grad et al. recently developed a wsPCIP hydrogel
with tunable mechanical properties via a similar crosslinking
method as described above, using coiled coils as crosslinks
instead of DNA,277 clearly demonstrating the potential of the
use of functional crosslinks.
Beyond functional hydrogels, tetra(ethylene glycol)PICPs
with azide handles have been developed into an efficient artifi-
cial dendritic cell scaffold.262,278 For antibody conjugation to
the wsPICP backbone, BCN-functionalized Sav was linked to
the polymer by the SPAAC reaction (Fig. 34D).278 Biotinylated
αCD3 and αCD28 antibodies were then coupled to the polymer
through biotin–Sav interactions. In vitro T cell experiments
demonstrated that the antibody functionalized polymers were
able to activate T cells at much lower concentrations than
soluble antibodies or antibodies immobilized on rigid PGLA
spheres. These results show that using the Sav approach also
relatively large biomolecules can be immobilized on a polymer
scaffold. Further work underlined the advantageous effect of
the semiflexible polymer scaffold in terms of multivalent
binding interactions.279 Increasing the polymer length and
antibody density enhanced the multivalent character of the
polymer and lowered the effective concentration required for T
cell activation. Furthermore, prolonged activation of the stimu-
lated T cells was observed, indicating that the synthetic dendri-
tic cells support T cell signaling. Eggermont et al. applied a
covalent coupling strategy with DBCO functionalized proteins
interleukin-2 and interferon-α and showed that binding of
cytokines in combination with αCD3 on a semiflexible scaffold
further optimizes T cell activation.280
While sequence control in synthetic polymers remains chal-
lenging, sequential addition of monomers during PIC
polymerization yields block copolymers. Voerman et al. pre-
pared blocks with two orthogonal functional groups; a small
block containing allyl groups for surface grafting and a larger
azide-containing block that enables a SPAAC-based introduc-
tion of bioactive molecules (Fig. 34E).281 The allyl handles
were conjugated with tetrazole-functionalized biotin linkers
via a nitrile-imine-mediated tetrazole-ene cycloaddition reac-
tion that allows binding to Sav-coated substrates. The authors
showed that the sequence of polymer grafting and functionali-
zation influenced the polymer density on the substrate as well
as the degree of substitution of the azide handles. First sub-
strate grafting, then bioconjugation with DBCO-functionalized
bovine serum albumin (BSA) resulted in surfaces with a high
density of polymer brushes but with a limited amount of
coupled BSA proteins. The reverse order gave more BSA conju-
gation per chain but fewer brushes on the substrate. These
experiments show how block copolymers facilitate introduc-
tion of substituents in a moderate spatially controlled manner
and simultaneously shows the challenges associated with
more complex orthogonal conjugation strategies.
Conclusion and perspective
Over the past years semiflexible polymers have emerged as
attractive scaffolds that are able to present many different
functional groups, ranging from small molecules to large pro-
teins. Their relatively linear conformation and ability to with-
stand deformations ensures an efficient presentation of these
groups, sometimes even with high spatially control. In this
Review Polymer Chemistry


































































































review, we focused on different methods to introduce func-
tional groups through conjugation strategies that are available
to introduce these substituents, either through covalent or
noncovalent bonding.
In summary, we consider three ways to conjugate substitu-
ents to a polymer (see Table 2): (1) via modification of the
monomers that comprise the polymer; (2) via modification of
the catalyst that initiates polymerization; and (3) via post-
polymerization functionalization. Typically, natural polymeric
scaffolds are functionalized through post-modification
approaches, while substituents can be introduced on synthetic
polymers via any method. Post functionalization strategies
offer the advantage of versatility –virtually any molecule can be
introduced– but offers limited control on the molecules’ posi-
tion on the scaffold. Introduction of a substituent via catalyst
modification ensures its position on the polymer chain-end
and is a functionalization strategy with high spatial control,
but low functional group density. Direct monomer modifi-
cation enables introduction of substituents with some control
over their position on the polymer chain by making use of
polymerization reactions such as block-copolymerization or
SPSS. The downside, however is that monomer modification is
laborious and demands that the introduced functional group
is tolerated by the polymerization technique, which may
severely limit the scope of this approach, particularly for the
field of semiflexible polymers. Introduction of functional
groups on a polymer chain that facilitate conjugation of substi-
tuents post-polymerization provides a versatile route and
allows for insertion of substituents with more spatial control.
Although this combination of monomer modification and post
polymerization functionalization has already been applied and
generated well-defined functionalized scaffolds, it is only
applicable for synthetic polymers and still requires laborious
monomer modification. A functionalization method that facili-
tates conjugation of substituents on polymer chains in a
spatially controlled manner would circumvent these bottle-
necks but, to the best of our knowledge, is yet to be revealed.
Finally, it is interesting to reflect where functional semiflex-
ible polymers may have the biggest impact. When we consider
the broad spectrum of applications discussed in this review, it
may be hard to predict. The field that currently jumps out
most clearly is chemical biology, which regularly requires
scaffolds to present one or multiple (similar or different)
chemical cues simultaneously. It may also be this particular
field, where the intrinsic benefits of semiflexible scaffolds, i.e.
an intermediate flexibility that offers excellent cue presen-
tation compared to flexible polymers and a more flexible con-
formation for multivalent binding compared to functional
nanoparticles, are optimally exploited.
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Most frequent applied chemical functionalization
strategiesa,b
Biopolymers
Polypeptides X NHS-chemistry (3), bifunctional linkers (3)
Polynucleotides:
- DNA Xc X NHS-chemistry (3), bifunctional linkers (3)
- RNA Xc X No chemical modification
- PNA X X Nucleobase modification (1,3), SPPS (1,3)
Polysaccharides X Amine coupling (3), NHS-chemistry (3)
Synthetic polymers
Polypeptides X X X NCA modification (1,3), SPPS (1,3), ROP initiation (2)
Conducting polymers:
- Polyacetylenes Xd Xe Chlorine substitution (3)
- Polyanilines Xd X (Thiol) surface modification (3)
- Polypyrroles X
Polyisocyanides Xd X X PFP substitution (3), SPAAC (3)
a For references we refer to the corresponding paragraphs in this review. bNumbers refer to classes of modifications 1–3. cMonomer modification
refers in this case to modification of oligonucleotides which assemble into larger structures. dMonomers are prepared through a wide variety of
synthetic routes instead of one or two often applied chemical strategies. e For disubstituted polyacetylene, post-polymerization functionalization
is possible (ref. 179).
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